Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Neurokinin-3 Receptor-Specific Antagonists Talnetant and Osanetant Show Distinct Mode of Action in Cellular Ca2+ Mobilization but Display Similar Binding Kinetics and Identical Mechanism of Binding in Ligand Cross-Competition

Gaochao Tian, Dee Wilkins and Clay W. Scott
Molecular Pharmacology March 2007, 71 (3) 902-911; DOI: https://doi.org/10.1124/mol.106.029868
Gaochao Tian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dee Wilkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clay W. Scott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 71 no. 3 902-911
DOI 
https://doi.org/10.1124/mol.106.029868
PubMed 
17172464

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 11, 2006
  • Accepted December 15, 2006
  • Published online February 16, 2007.

Article Versions

  • Earlier version (December 15, 2006 - 13:22).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Gaochao Tian,
  2. Dee Wilkins and
  3. Clay W. Scott
  1. Department of Lead Generation, AstraZeneca Pharmaceuticals, Wilmington, Delaware
  1. Address correspondence to:
    Dr. Gaochao Tian, AstraZeneca Pharmaceuticals, 1800 Concord Pike, Wilmington, DE 19803. E-mail: gaochao.tian{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2006 to August 2022

AbstractFullPdf
Dec 200620023
Jan 200719038
Feb 200760364
Mar 2007381739
Apr 2007311318
May 2007231113
Jun 200719812
Jul 200717610
Aug 2007181012
Sep 200714710
Oct 200716714
Nov 20072397
Dec 20071146
Jan 2008745
Feb 20082286
Mar 2008161114
Apr 2008142215
May 2008143519
Jun 2008121617
Jul 200820916
Aug 2008151312
Sep 2008192320
Oct 2008201914
Nov 2008764
Dec 2008447
Jan 200919116
Feb 20091345
Mar 200917119
Apr 200911223
May 20091086
Jun 2009673
Jul 200911146
Aug 200913106
Sep 20091095
Oct 2009842
Nov 20095511
Dec 2009654
Jan 20101444
Feb 20101025
Mar 20101581
Apr 20101866
May 2010141612
Jun 20101375
Jul 201011143
Aug 20104067
Sep 201015138
Oct 201013166
Nov 201010154
Dec 2010587
Jan 2011496
Feb 201118126
Mar 2011201316
Apr 201118128
May 201151114
Jun 201110126
Jul 20111479
Aug 201191115
Sep 20115118
Oct 2011986
Nov 2011131015
Dec 2011893
Jan 20128107
Feb 201251913
Mar 201215127
Apr 2012131210
May 201217512
Jun 20127912
Jul 2012191017
Aug 201291415
Sep 2012776
Oct 2012968
Nov 201231510
Dec 2012121013
Jan 2013657
Feb 20138115
Mar 201313106
Apr 201381113
May 20135179
Jun 20131047
Jul 2013727
Aug 20131068
Sep 20134125
Oct 201312128
Nov 2013393
Dec 2013362
Jan 201451210
Feb 2014575
Mar 20144159
Apr 2014875
May 2014584
Jun 20141116
Jul 20149142
Aug 20148106
Sep 2014323
Oct 20141064
Nov 2014498
Dec 20149244
Jan 20152517
Feb 2015640
Mar 20157109
Apr 2015552
May 20155108
Jun 20156113
Jul 201591417
Aug 20158155
Sep 2015261
Oct 2015276
Nov 2015342
Dec 20154158
Jan 20169137
Feb 20163619
Mar 20167210
Apr 20161341
May 2016573
Jun 2016471
Jul 20163512
Aug 20163812
Sep 20162811
Oct 20160107
Nov 20162158
Dec 2016077
Jan 201702910
Feb 201701316
Mar 2017099
Apr 201701015
May 20170618
Jun 20170132
Jul 2017472
Aug 201741610
Sep 2017274
Oct 2017342
Nov 2017295
Dec 20170151
Jan 2018073
Feb 20181112
Mar 2018171
Apr 20181175
May 20180115
Jun 20182113
Jul 20181141
Aug 2018165
Sep 2018062
Oct 20181164
Nov 20180105
Dec 2018423
Jan 2019815
Feb 2019404
Mar 20191506
Apr 2019507
May 20191417
Jun 20197010
Jul 201915110
Aug 20192528
Sep 20191207
Oct 20191717
Nov 20192017
Dec 20191803
Jan 2020802
Feb 20201500
Mar 2020826
Apr 2020801
May 2020301
Jun 2020600
Jul 2020800
Aug 2020100
Sep 2020401
Oct 20202012
Nov 20201102
Dec 20201621
Jan 20211632
Feb 20219104
Mar 20211721
Apr 20211310
May 2021933
Jun 2021820
Jul 20211933
Aug 20211632
Sep 20211124
Oct 2021520
Nov 2021910
Dec 20211511
Jan 20222010
Feb 2022400
Mar 20221921
Apr 20221311
May 2022412
Jun 20221801
Jul 2022913
Aug 20221000

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 71 (3)
Molecular Pharmacology
Vol. 71, Issue 3
1 Mar 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Neurokinin-3 Receptor-Specific Antagonists Talnetant and Osanetant Show Distinct Mode of Action in Cellular Ca2+ Mobilization but Display Similar Binding Kinetics and Identical Mechanism of Binding in Ligand Cross-Competition
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Neurokinin-3 Receptor-Specific Antagonists Talnetant and Osanetant Show Distinct Mode of Action in Cellular Ca2+ Mobilization but Display Similar Binding Kinetics and Identical Mechanism of Binding in Ligand Cross-Competition

Gaochao Tian, Dee Wilkins and Clay W. Scott
Molecular Pharmacology March 1, 2007, 71 (3) 902-911; DOI: https://doi.org/10.1124/mol.106.029868

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Neurokinin-3 Receptor-Specific Antagonists Talnetant and Osanetant Show Distinct Mode of Action in Cellular Ca2+ Mobilization but Display Similar Binding Kinetics and Identical Mechanism of Binding in Ligand Cross-Competition

Gaochao Tian, Dee Wilkins and Clay W. Scott
Molecular Pharmacology March 1, 2007, 71 (3) 902-911; DOI: https://doi.org/10.1124/mol.106.029868
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Appendix: Derivation of Equation 1 for Ligand Cross-Competition
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effects of Small Molecule Ligands on ACKR3 Receptors
  • Michaelis-Menten Quantification of GPCR-G Protein Signaling
  • Anti-aromatase activity of exemestane phase II metabolites
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics